FDA panel backs Amylyx's much-debated ALS drug
In a remarkable turnaround, a panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig's disease. Patients and their families have rallied behind Amylyx's drug, urging approval.